David C. Greenberg - 13 May 2025 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Director
Signature
By: Paula Darbyshire, Attorney-in-Fact For: David C. Greenberg
Issuer symbol
ICUI
Transactions as of
13 May 2025
Net transactions value
-$95,124
Form type
4
Filing time
13 May 2025, 19:37:55 UTC
Previous filing
27 Nov 2024
Next filing
27 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Greenberg David C. Director 951 CALLE AMANECER, SAN CLEMENTE By: Paula Darbyshire, Attorney-in-Fact For: David C. Greenberg 13 May 2025 0001645866

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +1,723 +34% $0.000000 6,760 13 May 2025 Direct F1
transaction ICUI Common Stock Options Exercise $183,869 +1,942 +29% $94.68 8,702 13 May 2025 Direct
transaction ICUI Common Stock Sale $278,992 -1,942 -22% $143.66 6,760 13 May 2025 Direct F1, F2
holding ICUI Common Stock 500 13 May 2025 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 -1,723 -100% $0.000000 0 13 May 2025 Common Stock 1,723 $0.000000 Direct F1, F3, F4
transaction ICUI Common Stock Award $0 +1,254 $0.000000 1,254 13 May 2025 Common Stock 1,254 $0.000000 Direct F1, F3, F4
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,942 -100% $0.000000 0 13 May 2025 Common Stock 1,942 $94.68 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are Restricted Stock Units.
F2 All shares sold were sold at the exact price disclosed.
F3 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4 These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.